Potassium (R)-trifluoro((3-methylpiperidin-1-yl)methyl)borate

Catalog No.: 
ACHIVX648
CAS No.: 
2854432-84-9
Molecular Formula: 
C7H14BF3KN
Molecular Weight: 
219.10
Potassium (R)-trifluoro((3-methylpiperidin-1-yl)methyl)borate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NamePotassium (R)-trifluoro((3-methylpiperidin-1-yl)methyl)borate
IUPAC Namepotassium (R)-trifluoro((3-methylpiperidin-1-yl)methyl)borate
Molecular FormulaC7H14BF3KN
Molecular Weight219.10
SMILESC[C@H]1CN(C[B-](F)(F)F)CCC1.[K+]
InChI KeyIVGVUNPPGPWALH-OGFXRTJISA-N
SynonymPotassium (R)-trifluoro((3-methylpiperidin-1-yl)methyl)borate;Borate(1-), trifluoro[[(3R)-3-methyl-1-piperidinyl]methyl]-, potassium (1:1), (T-4)-
CAS No.2854432-84-9

Synthetic Route by SureRoute

1. ACHIVX648 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRIAH901 route compound structure diagram
    ACRIAH901223792-48-1In Stock
  2. Plus
  3. ACOIDR094 route compound structure diagram
    ACOIDR094888711-47-5In Stock
  4. Then
  5. ACHIVX648 route product structure diagram
    ACHIVX6482854432-84-9
Inquiry

2. ACHIVX648 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRIAH901 route compound structure diagram
    ACRIAH901223792-48-1In Stock
  2. Plus
  3. ACUQCD364 route compound structure diagram
    ACUQCD3641279123-64-6In Stock
  4. Then
  5. ACHIVX648 route product structure diagram
    ACHIVX6482854432-84-9
Inquiry

3. ACHIVX648 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRIAH901 route compound structure diagram
    ACRIAH901223792-48-1In Stock
  2. Plus
  3. ACMDZJ903 route compound structure diagram
    ACMDZJ903888711-44-2In Stock
  4. Then
  5. ACHIVX648 route product structure diagram
    ACHIVX6482854432-84-9
Inquiry

Comments (0)